These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


301 related items for PubMed ID: 21319066

  • 1. [Depot antipsychotics in the year 2011].
    Knegtering H, Oolders H, Ruijsink MA, van der Moolen AE.
    Tijdschr Psychiatr; 2011; 53(2):95-105. PubMed ID: 21319066
    [Abstract] [Full Text] [Related]

  • 2. Choosing antipsychotic maintenance therapy--a naturalistic study.
    Tavcar R, Dernovsek MZ, Zvan V.
    Pharmacopsychiatry; 2000 Mar; 33(2):66-71. PubMed ID: 10761822
    [Abstract] [Full Text] [Related]

  • 3. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L, Abbar M, Courtet P, Guillaume S, Lancrenon S, Llorca PM.
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [Abstract] [Full Text] [Related]

  • 4. Treatment adherence in schizophrenia and schizoaffective disorder.
    Goff DC, Hill M, Freudenreich O.
    J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
    [Abstract] [Full Text] [Related]

  • 5. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ.
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [Abstract] [Full Text] [Related]

  • 6. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS, Stewart DW.
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [Abstract] [Full Text] [Related]

  • 7. Depot and oral antipsychotics: patient preferences and attitudes are not the same thing.
    Patel MX, De Zoysa N, Bernadt M, David A.
    J Psychopharmacol; 2009 Sep; 23(7):789-96. PubMed ID: 18583438
    [Abstract] [Full Text] [Related]

  • 8. Depot antipsychotics in practice. Their rôle in schizophrenia and related psychoses.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():1-78. PubMed ID: 2881965
    [No Abstract] [Full Text] [Related]

  • 9. The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable.
    Gharabawi G, Bossie C, Turkoz I, Kujawa M, Mahmoud R, Simpson G.
    J Nerv Ment Dis; 2007 Dec; 195(12):976-82. PubMed ID: 18091190
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Partial response to antipsychotic treatment: the patient with enduring symptoms.
    Emsley RA.
    J Clin Psychiatry; 1999 Dec; 60 Suppl 23():10-3. PubMed ID: 10625194
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dose response of prophylactic antipsychotics.
    Davis JM, Kane JM, Marder SR, Brauzer B, Gierl B, Schooler N, Casey DE, Hassan M.
    J Clin Psychiatry; 1993 Mar; 54 Suppl():24-30. PubMed ID: 8097195
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.